Trials / Unknown
UnknownNCT02369939
Effects of Deep Regional Hyperthermia in Patients With Anal Carcinoma Treated by Standard Radiochemotherapy
Randomized Trial to Evaluate Effects of Deep Regional Hyperthermia in Patients With Anal Carcinoma Treated by Standard Radiochemotherapy
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 118 (estimated)
- Sponsor
- University of Erlangen-Nürnberg Medical School · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Randomized study to investigate the efficacy of deep regional hyperthermia in patients with anal carcinoma treated by standard radiochemotherapy with MMC and 5-FU.
Detailed description
Pat. with anal carcinoma and treated with standard radiochemotherapy with Mitomycin C and 5-FU will in the experimental arm receive deep regional hyperthermia (6x).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | Irradiation | Radiotherapy 55,8 Gy - 59,4 Gy |
| DRUG | Mitomycin C | MMC w1, w5 |
| DRUG | 5-Fluorouracil | 5-FU w1, w5 |
| PROCEDURE | Hyperthermia | 6x deep regional hyperthermia |
Timeline
- Start date
- 2014-12-01
- Primary completion
- 2017-12-01
- Completion
- 2021-04-01
- First posted
- 2015-02-24
- Last updated
- 2017-08-11
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT02369939. Inclusion in this directory is not an endorsement.